ClinicalTrials.Veeva

Menu

Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease

I

Istituto Giannina Gaslini

Status

Completed

Conditions

Coronary Disease

Treatments

Diagnostic Test: stress cardiac MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT04022395
519REG2016

Details and patient eligibility

About

stress cMRI with Dobutamine stress agent (stress cMRI), represent the combination of two orders of exams routinely performed (cMRI and stress diagnostic series of exams) without additional risk for the patient, but with the advantage of non-invasiveness and lack of radiation, and less laborious for the participants

Full description

Surgical revascularization or angioplasty are therapeutic options for coronary lesions even in infants and children. Pharmacological stress induced cMRI could provide crucial information such as coronary arteries origin and proximal pathway, wall motion abnormalities, myocardial perfusion and viability, enabling accurate monitoring of symptomatic and non-pediatric patients. Investigators would build a prospective series of stress cMRI exams in pediatric symptomatic and non-patients, with suspected or previously diagnosed coronary artery disease. Investigators would put the results in comparison with ECG, Exercise test, stress Cardiac Ultrasound and Angiography. At the end of the study, if supported by results, the aim is to replace the current diagnostic procedure (ECG, Exercise test, stress Cardiac Ultrasound and Angiography) which need long hospitalization, expose the patient to radiation dose, is uncomfortable for the patient, and is characterized by a non-negligible risk due to invasive procedure, with a single exam (stress cMRI) which is dose-free, minimal risk related, without hospitalization, and less expensive for National Care System.

Enrollment

15 patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between 8 and 18 years-old patients symptomatic and non, with suspected or previously diagnosed coronary arteries disease

    • Coronary artery re-implantation after arterial switch
    • ALCAPA Syndrome, and other anomalies of origin or pathway
    • replacement of aortica valve with pulmonary autograft (Ross procedure)
    • Kawasaki disease
    • primary dilatative cardiomyopathy
    • coronary atresia
    • familiar Hypercholesterolemia
    • bicuspid aortic valve
    • chest pain
    • exertional dyspnea of suspected coronary artery nature
    • coronary artery fistula

Exclusion criteria

  • General contraindication to MRI (non MRI compatible device: vascular clips, foreign bodies, coronary and peripheral artery stents, aortic stent grafts, prosthetic heart valves and annuloplasty rings, cardiac occluder devices, vena cava filters and embolisation coils, haemodynamic monitoring and temporary pacing devices, haemodynamic support devices, permanent cardiac pacemakers and implantable cardioverter-defibrillators, retained transvenous pacemaker and defibrillator leads, cochlear implants, claustrophobia, pregnancy and postpartum),

    • contraindication to contrast agent (renal insufficiency, hypersensitivity to the Dotarem active substance or to any of the excipients:)
    • contraindication to stress agent (hypersensitivity to Dobutamine active substance or to any of the excipients)
    • severe arterial hypertension (>/= 220/120 mmHg)
    • unstable angina pectoris
    • significant aortic stenosis
    • complex cardiac arrhythmias including uncontrolled atrial fibrillation
    • hypertrophic obstructive cardiomyopathy
    • myocarditis, endocerditis
    • pericarditis
    • uncontrolled congestive heart failure
    • previous manifestations of hypersensitivity to dobutamine
    • refuse to join the protocol and relative off-label procedures

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

stress cardiac MRI
Experimental group
Description:
* To optimize the scan protocol and the sequence parameters * To investigate the clinical compliance of stress induced cardiac MRI in pediatric patients * To test the ability of stress cMRI to visualize coronary arteries morphological irregularities, the corresponding wall motion abnormalities and perfusion - viability features
Treatment:
Diagnostic Test: stress cardiac MRI

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems